(Press-News.org) DETROIT – The American Tinnitus Association (ATA) has elected Jinsheng Zhang, Ph.D., professor and chair of the Department of Communication Sciences and Disorders in Wayne State University’s College of Liberal Arts and Sciences, as the new chair of its board of directors. With decades of experience in tinnitus research and work with the ATA, Zhang aims to assist with proactive recruitment of scientists to the field of tinnitus and engage more researchers in ATA grant opportunities that will spur progress toward more effective treatments and cures.
Tinnitus is a common auditory condition that affects millions of people in the United States and can present as a variety of sounds — including ringing, buzzing or clicking — that can be heard only by the person with the condition. Whereas some habituate quickly to the sound, others find it difficult to ignore, which can lead to insomnia, increased anxiety, depression and suicidal ideation. Evidence-based interventions are available to alleviate the negative effects of tinnitus, but access to care remains an obstacle, as does consistent care within the health care industry.
“I’ve been affiliated with the ATA for nearly two decades, as a seed grant recipient early in my career, chair of the Scientific Advisory Committee in more recent years and board member,” said Zhang. “I believe in the work of the ATA and want to lead the way toward more significant investment in cutting-edge research and attracting new talent to the field.”
It is often difficult to retain researchers in the field of tinnitus research because of limited funding and the challenge of understanding the underlying mechanisms of a condition with no objective measure, which can be caused by numerous factors such as hormonal imbalances, high blood pressure, stress and noise exposure. Zhang emphasized that the ATA seed grant he received in 2005 was pivotal in his decision to stay in the field.
Zhang currently leads an $8.6 million Department of Defense-funded multicenter clinical trial to develop a pharmaceutical treatment for tinnitus, which is the leading disability among veterans. Along with his department chair role, he also serves as research director in the Department of Otolaryngology in Wayne State’s School of Medicine and as director of laboratories for tinnitus and auditory neuroscience research.
“We’re thrilled to have Dr. Zhang as our new board chair as of July 1, at a time when the ATA has sufficient funds for research grant investment. Thanks to individual donors and the generosity of Texas Roadhouse — which has hosted two extraordinary fundraisers for the ATA in honor of their late founder, Kent Taylor, who struggled with severe tinnitus the last year of his life — we’re able to review grants throughout the year, not just once a year,” said David Hadley, current chair of the board of directors.
The ATA’s Innovative Grants Program fills a critical need for researchers pursuing novel investigations that require funds to test a theory and, if successful, produce data that can be used to apply for funding from larger institutions. The ATA funding model enables individuals to contribute directly to research and encourages researchers to explore the boundaries of what is currently known.
The ATA Board of Directors guides the organization in its mission and efforts to meet the needs of the public, including educating physicians on how tinnitus can be managed, helping patients find qualified health care providers, and providing seed funding for research that could lead to breakthroughs.
The ATA operates the Tinnitus Advisors Program call line, a free, one-time 15-minute consultation intended to help callers understand management strategies, direct them to appropriate health care providers and answer questions. The ATA does not provide medical guidance, and always recommends that people be properly evaluated by their physician when tinnitus develops or changes, since that can indicate an underlying medical issue, which, when addressed, may result in the elimination or reduction of the sound. To speak with an ATA advisor, call 1-800-634-8978, ext. 3. If tinnitus symptoms are causing severe distress, call 911 or the 988 crisis hotline for immediate help.
About the American Tinnitus Association
The core purpose of the American Tinnitus Association is to promote relief and to prevent and find cures for tinnitus, as evidenced by its core values of compassion, credibility, and responsibility. The leading cause of tinnitus is exposure to loud sound that damages an individual's auditory system; the second leading cause is head or neck trauma. Tinnitus also is the leading service-connected disability for U.S. veterans. The ATA is funded by individual donors and a handful of companies to fulfill its critical mission. Please donate and/or consider becoming a member so the ATA can continue to improve the quality of life for those living with tinnitus and to educate the public on prevention of the condition. To learn more, visit ATA.org.
About Wayne State University
Wayne State University is one of the nation’s pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit research.wayne.edu.
The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and educational sessions. The course is designed for all clinicians who provide cardiovascular care for the professional, occupational, tactical or recreational athlete. As the athletic population expands to all demographic groups, it is critical that there is a larger contingent of clinicians who understand the latest care and practice management for athletes at every level.
Dermot Phelan, BAO, MBBCh, PhD, FACC, and Megan Wasfy, ...
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years. The authors caution that these benefits must be weighed against risk of toxicity, but, overall, the study shows promising results that warrant larger studies and efforts to identify patients most likely to benefit from this treatment. Their findings are published in Nature Medicine and presented simultaneously at the 2023 ASCO Annual Meeting on June 2.
The paper, published April 17 in The Lancet Regional Health – Americas, was co-authored by Dr. Gunisha Kaur, an associate professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights; Stephen Yale-Loehr, a professor of immigration law practice at Cornell Law School; and Jin K. Park, a medical student at the Harvard School of Medicine and the first DACA recipient awarded a Rhodes Scholarship.
“The erratic enforcement of the DACA program since its inception has led many immigrants and their families to disengage completely from the healthcare system to avoid risking deportation,” said ...
Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients. A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment.
The three grants combined total $6.1 million.
During the pandemic, health care providers worked tirelessly to treat patients ...
WASHINGTON --- Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias.
The findings will be presented at the American Society of Clinical Oncology 2023 annual meeting in Chicago in June.
Agent Orange is an herbicide that was utilized by the United States military ...
The US Food and Drug Administration (FDA) mandated folic acid fortification of all enriched cereal grains in 1996, and this regulation resulted in a reduction of neural tube defect (NTD)–affected pregnancies for the population in the United States. While this mandatory food fortification strategy is an example of a public health success, Hispanic women in the US continued to be twice as likely to give birth to a child affected by NTD compared to non-Hispanic women. It was not until the year 2016 that the FDA approved voluntary, but not mandatory, folic acid fortification for corn masa flour products in the US to focus on the Hispanic diet staples, such ...
Usually, the two characterizations of a material are mutually exclusive: something is either stiff, or it can absorb vibrations well – but rarely both. However, if we could make materials that are both stiff and good at absorbing vibrations, there would be a whole host of potential applications, from design at the nano-scale to aerospace engineering.
Buckling does the trick
A team of researchers from the University of Amsterdam has now found a way to create materials that are stiff, but still good at absorbing vibrations – and equally importantly, that can be kept very light-weight. David Dykstra, lead author of the ...
NEW YORK, N.Y. — June 2. Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis. Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, will help Novartis Pharmaceuticals Corporation (Novartis) conduct the trials through the Lupus Clinical Investigators Network (LuCIN) at top academic centers throughout North America.
Lupus is a devastating heterogeneous autoimmune disease affecting millions worldwide with symptoms that can range from debilitating fatigue to ...
About The Study: In this randomized crossover trial of autistic children, using a sensory-adapted dental environment was safe and efficacious in decreasing physiological and behavioral distress during dental care. This is important because enhancing oral care is critical for autistic children; this intervention may also be beneficial for populations beyond autism.
Authors: Leah I. Stein Duker, Ph.D., O.T.R./L., of the University of Southern California in Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website ...
About The Study: This qualitative study found that participants perceived widespread and increasing use of algorithms in health care and lack of oversight, potentially exacerbating racial and ethnic inequities. Increasing awareness for clinicians and patients and standardized, transparent approaches for algorithm development and implementation may be needed to address racial and ethnic biases related to algorithms.
Authors: Peter Treitler, M.S.W., of Rutgers University in New Brunswick, New Jersey, is the corresponding author.